It has proved difficult to develop biosimilars of the antibody due to its structural complexity. “With our expertise in the treatment of CRC, and based on the encouraging early data for ...
Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...
South Korean biotech firms are targeting the $26 billion biosimilar market opening up as patents expire on more than 10 blockbuster drugs in the United States this year. Biosimilars are copies of ...
SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics ...
The posters can be accessed through the “Supporting Publications” tab on the “Our Approach” section of the Zentalis website at the time of each presentation’s starting session. Azenosertib is a novel, ...
The Banking of Biosimilars: Insights From a Leading Health Economist ...
The Banking of Biosimilars: Insights From a Leading Health Economist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback